ConductScience.org, home

Paper19258929

Explaining variability in tacrolimus pharmacokinetics to optimize early exposure in adult kidney transplant recipients.

Press RR and 7 others. Ther Drug Monit, 2009. Cited by 117 papers, by iCite.

Cite this record

ConductScience Library. Explaining variability in tacrolimus pharmacokinetics to optimize early exposure in adult kidney transplant recipients. Papers, record 19258929. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19258929

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Explaining variability in tacrolimus pharmacokinetics to optimize early exposure in adult kidney transplant recipients.
PubMed
Journal
Ther Drug Monit
PubMed
Year
2009
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
117
iCite
Relative citation ratio, by iCite
4.16
iCite
Revised in PubMed
2018-12-01
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Press RRRogier R
2Ploeger BABart A
3den Hartigh JJan
4van der Straaten TTahar
5van Pelt JJohannes
6Danhof MMeindert
7de Fijter JWJohan W
8Guchelaar HJHenk-Jan

Source PubMed

Download CSV of authors

Topics23

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Immunosuppressive AgentsMajor topic
Kidney TransplantationMajor topic
TacrolimusMajor topic
Adult
Area Under Curve
Body Weight
Cytochrome P-450 CYP3A
Demography
Drug Administration Schedule
Drug Monitoring
Female
Hematocrit
Humans
Male
Metabolic Clearance Rate
Middle Aged
Polymorphism, Genetic
Prednisolone
Pregnane X Receptor
Prospective Studies
Randomized Controlled Trials as Topic
Receptors, Steroid
Serum Albumin

Source PubMed

Download CSV of topics

Cited by69

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 117 citations.

PMIDTitleJournalYearIn PapersSource
42477302A Review of Population Pharmacokinetic Models and Dosing Algorithms Assessing the Influence of CYP3A5 Genotype and Other Clinical Covariates on Tacrolimus Pharmacokinetics.Clin Pharmacokinet2026https://conductscience.org/library/papers/42477302PubMed
41673983Accelerating tacrolimus model-informed precision dosing in kidney transplant recipients: Model evaluation and refinement strategies.Br J Clin Pharmacol2026https://conductscience.org/library/papers/41673983PubMed
40936106Refining tacrolimus dosing through CYP3A5 pharmacogenetics in Taiwanese renal transplant recipients.Ren Fail2025https://conductscience.org/library/papers/40936106PubMed
40709926Tacrolimus Exposure is Associated with Acute Rejection in the Early Phase After Kidney Transplantation: A Joint Modeling Approach.Ther Drug Monit2025https://conductscience.org/library/papers/40709926PubMed
40632895Effect of CYP3A4 Methylation on Tacrolimus Pharmacokinetics.Ther Drug Monit2025https://conductscience.org/library/papers/40632895PubMed
40588615A Population Pharmacokinetic Model and Dosing Algorithm to Guide the Tacrolimus Starting and Follow-Up Dose in Living and Deceased Donor Kidney Transplant Recipients.Clin Pharmacokinet2025https://conductscience.org/library/papers/40588615PubMed
40104905The tacrolimus concentration-to-dose ratio is associated with kidney function in heart transplant recipients.Br J Clin Pharmacol2025https://conductscience.org/library/papers/40104905PubMed
39390741Population pharmacokinetics of tacrolimus whole blood and peripheral blood mononuclear cell concentrations in stable kidney-transplanted patients.Br J Clin Pharmacol2025https://conductscience.org/library/papers/39390741PubMed
39304577Model-Informed Precision Dosing of Tacrolimus: A Systematic Review of Population Pharmacokinetic Models and a Benchmark Study of Software Tools.Clin Pharmacokinet2024https://conductscience.org/library/papers/39304577PubMed
38994750Steroid-tacrolimus drug-drug interaction and the effect of CYP3A genotypes.Br J Clin Pharmacol2024https://conductscience.org/library/papers/38994750PubMed
38276495Meltdose Tacrolimus Population Pharmacokinetics and Limited Sampling Strategy Evaluation in Elderly Kidney Transplant Recipients.Pharmaceutics2023https://conductscience.org/library/papers/38276495PubMed
37261481Population pharmacokinetic analyses of tacrolimus in non-transplant patients: a systematic review.Eur J Clin Pharmacol2023https://conductscience.org/library/papers/37261481PubMed
36239542Adaptation of a population pharmacokinetic model to inform tacrolimus therapy in heart transplant recipients.Br J Clin Pharmacol2023https://conductscience.org/library/papers/36239542PubMed
35567629Body composition is associated with tacrolimus pharmacokinetics in kidney transplant recipients.Eur J Clin Pharmacol2022https://conductscience.org/library/papers/35567629PubMed
35020971Predicting model-informed precision dosing: A test-case in tacrolimus dose adaptation for kidney transplant recipients.CPT Pharmacometrics Syst Pharmacol2022https://conductscience.org/library/papers/35020971PubMed
34511980Wuzhi Capsule Dosage Affects Tacrolimus Elimination in Adult Kidney Transplant Recipients, as Determined by a Population Pharmacokinetics Analysis.Pharmgenomics Pers Med2021https://conductscience.org/library/papers/34511980PubMed
33649515Functional CYP3A variants affecting tacrolimus trough blood concentrations in Chinese renal transplant recipients.Pharmacogenomics J2021https://conductscience.org/library/papers/33649515PubMed
33512723Precision Dosing for Tacrolimus Using Genotypes and Clinical Factors in Kidney Transplant Recipients of European Ancestry.J Clin Pharmacol2021https://conductscience.org/library/papers/33512723PubMed
33452682Avoiding Tacrolimus Underexposure and Overexposure with a Dosing Algorithm for Renal Transplant Recipients: A Single Arm Prospective Intervention Trial.Clin Pharmacol Ther2021https://conductscience.org/library/papers/33452682PubMed
33025649Monitoring the tacrolimus concentration in peripheral blood mononuclear cells of kidney transplant recipients.Br J Clin Pharmacol2021https://conductscience.org/library/papers/33025649PubMed

See all 69 cited byDownload CSV of cited by

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABCB15243PubTator's text mininghttps://conductscience.org/library/genes/5243NCBI Gene
ALB213PubTator's text mininghttps://conductscience.org/library/genes/213NCBI Gene
CYP3A41576PubTator's text mininghttps://conductscience.org/library/genes/1576NCBI Gene
CYP3A51577PubTator's text mininghttps://conductscience.org/library/genes/1577NCBI Gene
NR1I28856PubTator's text mininghttps://conductscience.org/library/genes/8856NCBI Gene
RXRA6256PubTator's text mininghttps://conductscience.org/library/genes/6256NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19258929

GET https://conductscience.org/api/papers/v1/19258929/cited_by?page=2